Advertisement

Table of Contents

September 11, 2018; 2 (17)

REVIEW ARTICLE

CLINICAL TRIALS AND OBSERVATIONS

  • Ravulizumab (ALXN1210) in patients with paroxysmal nocturnal hemoglobinuria: results of 2 phase 1b/2 studies
    Ravulizumab (ALXN1210) in patients with paroxysmal nocturnal hemoglobinuria: results of 2 phase 1b/2 studies
    Alexander Röth, Scott T. Rottinghaus, Anita Hill, Eric S. Bachman, Jin Seok Kim, Hubert Schrezenmeier, Louis Terriou, Álvaro Urbano-Ispizua, Richard A. Wells, Jun Ho Jang, Austin G. Kulasekararaj, Jeff Szer, Rasha Aguzzi, Andrew I. Damokosh, Lori Shafner and Jong Wook Lee
  • Is a matched unrelated donor search needed for all allogeneic transplant candidates?
    Is a matched unrelated donor search needed for all allogeneic transplant candidates?
    Stefan O. Ciurea, Maria Cecilia Borges Bittencourt, Denái R. Milton, Kai Cao, Piyanuch Kongtim, Gabriela Rondon, Julianne Chen, Marina Konopleva, Jorge M. Ramos Perez, Mohammed F. El Shazly, Majdi Aljadayeh, Michele Alvarez, Jin Im, Gheath Al-Atrash, Rohtesh Mehta, Uday Popat, Qaiser Bashir, Betul Oran, Chitra M. Hosing, Issa F. Khouri, Partow Kebriaei and Richard E. Champlin

IMMUNOBIOLOGY AND IMMUNOTHERAPY

LYMPHOID NEOPLASIA

PLATELETS AND THROMBOPOIESIS

THROMBOSIS AND HEMOSTASIS

TRANSPLANTATION